Literature DB >> 9765498

Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.

M Tamura1, K Kuwano, I Kurane, F A Ennis.   

Abstract

We defined the epitopes recognized by three influenza A virus-specific, H-2Kd-restricted CD8(+) cytotoxic T-lymphocyte (CTL) clones: H1-specific clone A-12, H2-specific clone F-4, and H1- and H2-cross-reactive clone B7-B7. The A-12 and B7-B7 clones recognized the same peptide, which comprises amino acids 533 to 541 (IYSTVASSL) of A/PR/8 hemagglutinin (HA). The F-4 and B7-B7 clones both recognized the peptide which comprise amino acids 529 to 537 (IYATVAGSL) of A/Jap HA. Amino acids 533 to 541 of A/PR/8 HA are compatible with amino acids 529 to 537 of A/Jap HA. Amino acid S at positions 3 and 7 was responsible for recognition by H1-specific clone A-12, while amino acid G at position 7 was responsible for recognition by H2-specific clone F-4. Two conserved amino acids, T at position 4 and A at position 6, were responsible for recognition by H1-, and H2-cross-reactive clone B7-B7. These results indicate that a single nine-amino-acid region is recognized by HA-specific CTL clones of three different subtype specificities and that the amino acids responsible for the recognition by the CTL clones are different.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765498      PMCID: PMC110370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone.

Authors:  K Kuwano; M Tamura; F A Ennis
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

2.  Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone.

Authors:  K Kuwano; V E Reyes; R E Humphreys; F A Ennis
Journal:  Mol Immunol       Date:  1991 Jan-Feb       Impact factor: 4.407

3.  Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus.

Authors:  K U Saikh; M Tamura; K Kuwano; L C Dai; K West; F A Ennis
Journal:  Viral Immunol       Date:  1993       Impact factor: 2.257

4.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

5.  Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones.

Authors:  L Zeng; I Kurane; Y Okamoto; F A Ennis; M A Brinton
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia.

Authors:  M A Wells; F A Ennis; P Albrecht
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

Authors:  K Kuwano; T J Braciale; F A Ennis
Journal:  Viral Immunol       Date:  1989       Impact factor: 2.257

8.  Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.

Authors:  P G Livingston; I Kurane; L C Dai; Y Okamoto; C J Lai; R Men; S Karaki; M Takiguchi; F A Ennis
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

9.  Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.

Authors:  K Kuwano; M Scott; J F Young; F A Ennis
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.

Authors:  Y L Lin; B A Askonas
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

  10 in total
  10 in total

1.  DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

Authors:  Gunnveig Grodeland; Siri Mjaaland; Kenneth H Roux; Agnete Brunsvik Fredriksen; Bjarne Bogen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

2.  Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.

Authors:  Florian Krammer; Natalie Pica; Rong Hai; Irina Margine; Peter Palese
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

3.  Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.

Authors:  Ane Marie Anderson; Marta Baranowska-Hustad; Ranveig Braathen; Gunnveig Grodeland; Bjarne Bogen
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

4.  Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

Authors:  Claire Lhuillier; Nils-Petter Rudqvist; Takahiro Yamazaki; Tuo Zhang; Maud Charpentier; Lorenzo Galluzzi; Noah Dephoure; Cristina C Clement; Laura Santambrogio; Xi Kathy Zhou; Silvia C Formenti; Sandra Demaria
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

5.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

6.  The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.

Authors:  Shixia Wang; Chunghua Zhang; Lu Zhang; Jun Li; Zuhu Huang; Shan Lu
Journal:  Vaccine       Date:  2008-03-06       Impact factor: 3.641

7.  Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.

Authors:  Max Warncke; Maike Buchner; Gudrun Thaller; Anna Dodero; Alla Bulashevska; Dietmar Pfeifer; Jens Timmer; Hendrik Veelken
Journal:  Cancer Immunol Immunother       Date:  2010-09-17       Impact factor: 6.968

8.  MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination.

Authors:  Yeonsu Kim; Xiaoyan Zheng; Kathrin Eschke; M Zeeshan Chaudhry; Federico Bertoglio; Adriana Tomić; Astrid Krmpotić; Markus Hoffmann; Yotam Bar-On; Julia Boehme; Dunja Bruder; Thomas Ebensen; Linda Brunotte; Stephan Ludwig; Martin Messerle; Carlos Guzman; Ofer Mandelboim; Michael Hust; Stefan Pöhlmann; Stipan Jonjić; Luka Čičin-Šain
Journal:  Cell Mol Immunol       Date:  2022-01-07       Impact factor: 11.530

9.  The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype.

Authors:  Gunnveig Grødeland; Siri Mjaaland; Gro Tunheim; Agnete B Fredriksen; Bjarne Bogen
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.

Authors:  Xiaoyan Zheng; Jennifer D Oduro; Julia D Boehme; Lisa Borkner; Thomas Ebensen; Ulrike Heise; Marcus Gereke; Marina C Pils; Astrid Krmpotic; Carlos A Guzmán; Dunja Bruder; Luka Čičin-Šain
Journal:  PLoS Pathog       Date:  2019-09-16       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.